Crystagen: Dosage, Benefits & Side Effects
By Peptide Assistant Editorial Team · · · 7 sources cited
Overview
Crystagen is a Khavinson bioregulator tripeptide (Glu-Asp-Pro) that its developers class as an immunoprotector. The one published experiment, in aging spleen tissue, found that it activated B-cells. Effects on T-cell maturation or on the thymic output that critically declines with age (thymic involution) have not been published. It is marketed in anti-aging medicine to counteract immunosenescence, but no published human study shows that it maintains the immune competence that naturally erodes after age 40, leaving older adults increasingly vulnerable to infections, cancer, and autoimmune dysregulation.
Mechanism of Action
Crystagen is proposed to modulate gene expression in immune cells. Computer docking predicts that the tripeptide Glu-Asp-Pro binds a specific DNA sequence (AGAT), and in aging spleen tissue it activated B-cells without stimulating cell renewal. The effects listed below are claimed for the peptide but have not been shown in published studies: - **Thymic function:** Promotes thymic epithelial cell viability and function, supporting the maturation and positive selection of naive T-cells. This is crucial because thymic involution (shrinkage) is one of the primary drivers of age-related immune decline. - **T-cell differentiation:** Supports the balance between CD4+ helper and CD8+ cytotoxic T-cells, optimizing the CD4/CD8 ratio which often becomes skewed with aging. - **Cytokine regulation:** Modulates the cytokine profile, enhancing Th1 responses (IFN-γ, IL-2) important for antiviral and anticancer immunity while moderating excessive Th2 and pro-inflammatory (IL-6, TNF-α) signaling that characterizes 'inflammaging.' - **NK cell support:** May enhance natural killer cell activity, an important component of innate immunity that declines with age. Like other bioregulators, Crystagen is proposed to restore age-depleted tissue-specific peptide levels and shift immune cell gene expression toward a younger, more functional phenotype. Whether it can cause immune overstimulation or autoimmune activation has not been studied.
Crystagen Benefits: What the Research Shows
- A Khavinson Institute study in aging spleen tissue found that Crystagen activated B-cells but did not stimulate cell renewal. No published study of CD4/CD8 ratios in patients receiving Crystagen was found.
- Computer docking studies predict that the tripeptide binds the DNA sequence AGAT and can be carried into cells by LAT and PEPT transporters. No study of thymic output in aged animals was found.
- A long-term study in elderly people reported improved immune indices and a 2.0–2.4-fold lower incidence of acute respiratory disease, but it tested the thymus extract Thymalin and the pineal extract Epithalamin, not Crystagen. Vaccination response was not reported.
- No published human study of Crystagen was found. The clinical experience this group has published concerns other preparations (Thymalin, Thymogen, Vilon, Epithalamin, Prostatilen, Cortexin, Retinalamin).
Crystagen Dosage
- Standard dose: 10 mg subcutaneous injection daily.
- Typical cycle: 10–20 days.
- Repeat every 3–6 months, ideally with one cycle before cold/flu season (October–November) and one in early spring.
- Can be combined with Thymosin Alpha-1 for enhanced immune support — Crystagen provides epigenetic immune restoration while TA-1 provides direct immune activation.
- Part of seasonal bioregulator anti-aging protocols alongside tissue-specific bioregulators for other systems.
- No food timing restrictions. Inject subcutaneously.
Disclaimer: Dosing information is compiled from research literature and community protocols for educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol.
Crystagen Side Effects & Safety
Known Side Effects
- Injection site reactions — mild and uncommon.
- Immune overstimulation and autoimmune exacerbation have not been assessed; there is no published human study of Crystagen.
- Cytokine effects in people have not been studied, so the risk of an excessive immune response is unknown.
- Interactions with vaccinations or antimicrobial therapy have not been studied.
- Short treatment cycles minimize any theoretical risks.
Safety Profile
Crystagen has no published human safety study, including in elderly or immunocompromised people, the groups most in need of immune support and most vulnerable to immune-modulating side effects. The claim that it normalizes immune function rather than stimulating it non-specifically has not been tested, which matters for patients with autoimmune conditions or immune dysregulation. Whether it can cause cytokine storms, immune overstimulation, or autoimmune flares is unknown. Contraindications: organ transplant recipients on immunosuppressive therapy (theoretical risk of altering the immune balance that suppression is designed to maintain), active autoimmune disease in flare (use during remission may be appropriate — consult immunologist), and pregnancy/breastfeeding. Drug interactions have not been studied, including with antibiotics, antivirals, and standard medical treatments.
What to Expect
Days 1–10: No immediate subjective effects. The bioregulator is modulating gene expression in thymic and immune cells. Immune function changes are occurring at the cellular level but are not perceptible. Days 11–20: The immune epigenetic reset is establishing. No subjective changes expected during this period. Weeks 3–8 (post-cycle): Suppliers and users describe increased resistance to common infections, faster recovery from minor illnesses, and improved general vitality. These reports are anecdotal; no published study has measured lymphocyte counts or CD4/CD8 ratios after Crystagen. Months 2–6: Benefits persist throughout the inter-cycle period. Fewer and milder respiratory infections is the benefit users most often report; it has not been tested in a trial, and an effect on vaccination responses has not been studied. Repeat cycles maintain the immune benefits and are recommended before each cold/flu season.
Common Stacks
Thymosin Alpha-1
Thymosin Alpha-1 provides direct T-cell activation and immune enhancement through different signaling pathways, complementing Crystagen's epigenetic immune restoration for layered immune support.
Bronchogen
Bronchogen supports respiratory tissue integrity while Crystagen supports immune defense — together they provide comprehensive protection against respiratory infections, particularly relevant for elderly populations.
Cortagen
Brain and immune health are deeply interconnected through neuroimmune pathways. Cortagen supports cortical function while Crystagen supports immune competence, addressing two of the most critical systems affected by aging.
Storage & Handling
Store lyophilized powder refrigerated at 36–46°F (2–8°C). After reconstitution, refrigerate and use within 20 days. Unreconstituted powder shelf life: 24 months. Oral capsules: room temperature, cool and dry.
Pricing & Available Variants
Prices sourced from peptides.gg marketplace. Prices may vary.
References
- Сhervyakova NA, Linkova NS, Chalisova NI, et al. Molecular aspects of immunoprotective activity of peptides in spleen during the ageing process. Adv Gerontol. 2014.
- Khavinson V, Linkova N, Kozhevnikova E, et al. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. Int J Mol Sci. 2022.
- Khavinson VK, Lin'kova NS, Tarnovskaya SI. Short Peptides Regulate Gene Expression. Bull Exp Biol Med. 2016.
- Khavinson VK, Linkova NS, Rudskoy AI, et al. Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters. Biomolecules. 2023.
- Khavinson VK, Popovich IG, Linkova NS, et al. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021.
- Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003.
- Khavinson VKh, Kuznik BI, Ryzhak GA. Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results. Adv Gerontol. 2013.
Related Peptides
Track Crystagen in Your Protocol
Log your Crystagen doses, track consistency, and monitor your protocol with Peptide Assistant — completely free.
Start Tracking Free